Study guide
13.2 Sputum Sample Collection: Spontaneous and Induced Specimens
Certified Pulmonary Function Technologist CPFT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Overview & NBRC Certification Requirements
1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing
2 Chapter 2: Spirometry Equipment & Sensors
2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification
3 Chapter 3: Body Plethysmography & Hardware
3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography
4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control
4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices
5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria
5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops
6 Chapter 6: Lung Volume Determination Protocols
6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods
7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing
7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education
8 Chapter 8: Cardiopulmonary Exercise & ABG Testing
8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis
9 Chapter 9: Reference Values & PFT Calculations
9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations
10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation
10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols
11 Chapter 11: Artifact Recognition & Quality Assurance
11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance
12 Chapter 12: Documentation, Compliance, & Emergency Safety
12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab
13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data
13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management
13.2 Sputum Sample Collection: Spontaneous and Induced Specimens
Key Takeaways Explain This Topic AI
Sputum sample collection is Domain II task 5 and is examined under all three task verbs: selecting the method, performing the collection, and evaluating specimen validity.
Sputum induction uses nebulized hypertonic saline, typically 3% to 5% and sometimes escalating to 7%, delivered by ultrasonic nebulizer over roughly 15 to 20 minutes.
Induction is a bronchoconstriction risk, so baseline spirometry is required, pretreatment with a short-acting bronchodilator is standard, and FEV1 is monitored between saline periods.
A fall in FEV1 of 20% or more from the post-bronchodilator baseline, or significant symptoms, terminates the induction.
Specimen adequacy for bacteriology is judged microscopically: more than 25 neutrophils and fewer than 10 squamous epithelial cells per low-power field indicates lower respiratory tract material rather than saliva.
Last updated: August 2026
13.2 Sputum Sample Collection: Spontaneous and Induced Specimens
Sputum sample collection is item 5 in Domain II of the PFT Detailed Content Outline, listed under Select Test Protocols and Equipment , Perform the Procedure , and Evaluate Validity of Result . Candidates routinely skip it because it does not produce a number on a PFT report. It is nonetheless a technologist procedure with a real safety profile — induction is an aerosol-generating procedure that can provoke bronchospasm — and specimen validity is a genuine analytical judgment.
Indications and Method Selection
- Clinical Question Typical Specimen Requirement
- Bacterial pneumonia, exacerbation pathogen identification Gram stain and culture
Suspected pulmonary tuberculosis Three specimens for acid-fast bacilli smear and culture (or a single induced specimen with nucleic acid amplification, per current local protocol)
- Pneumocystis jirovecii in immunocompromised patients Induced specimen with special stains
- Suspected malignancy Cytology, classically on serial early-morning specimens
Airway inflammation phenotyping (research and severe asthma clinics) Induced specimen for differential cell count; eosinophil percentage guides therapy
Cystic fibrosis surveillance Culture, often induced in patients who cannot expectorate
Select spontaneous expectoration when the patient produces sputum readily. Select induction when the patient has a dry or minimally productive cough, when a standardized specimen is required for cell counts, or when a spontaneous sample has already proven to be saliva.
Spontaneous (Expectorated) Collection
Collect an early-morning specimen when possible; overnight pooling improves yield, particularly for mycobacteria and cytology.
Have the patient rinse the mouth with plain water — not mouthwash, which is antibacterial and will suppress culture growth. Remove dentures.
Instruct several deep breaths, then a deep cough from the chest , and expectoration directly into a sterile, wide-mouth, leak-proof container. Coach explicitly: "This should come from deep in your chest, not from your throat."
Target volume is small — 1 to 5 mL is sufficient ; volume is not a quality indicator.
Label at the bedside with patient identifiers, date, time, and collection method (spontaneous versus induced), and transport promptly. If a delay is unavoidable, refrigerate at 2–8 °C, except for specimens intended for Neisseria or certain fastidious organisms, and never freeze a specimen intended for cytology without laboratory instruction.
Sputum Induction with Hypertonic Saline
Hypertonic saline draws water osmotically into the airway lumen, thinning and mobilizing secretions while also stimulating cough. It is effective and it is provocative — the same osmotic stimulus is used deliberately as an indirect bronchial challenge.
Equipment
Ultrasonic nebulizer with a high output rate (commonly 1–3 mL/min); a standard jet nebulizer produces too little aerosol for reliable induction.
Sterile hypertonic saline , usually 3% , with protocols escalating through 4% and 5% and, in some, to 7% .
Spirometer for FEV 1 _1 1 monitoring, pulse oximeter, short-acting bronchodilator, sterile collection containers, and emergency equipment.
Protocol
Screen and consent. Confirm no relevant contraindication and explain the procedure and the salty taste.
Baseline spirometry. Record FEV 1 _1 1 . Induction is generally avoided when baseline FEV 1 _1 1 is below 1.0 L or below 60% predicted without direct physician supervision.
Pretreat with a short-acting bronchodilator (commonly albuterol 200 µg by MDI with a spacer, or 2.5 mg nebulized) and wait 10–15 minutes.
Repeat spirometry. This post-bronchodilator FEV 1 _1 1 becomes the reference baseline against which all subsequent falls are measured.
Nebulize the hypertonic saline in timed periods — typically 5-minute periods to a total of about 15–20 minutes .
Between each period: have the patient rinse the mouth with water, blow the nose, and cough deeply into the container; then repeat FEV 1 _1 1 .
Terminate immediately for a fall in FEV 1 _1 1 of ≥ \ge ≥ 20% from the post-bronchodilator baseline, for wheeze, chest tightness, or significant dyspnea, or at the patient's request. Some protocols step down rather than stop for a 10–20% fall; follow the laboratory's written protocol.
Post-procedure: administer bronchodilator if any fall occurred and observe until FEV 1 _1 1 returns to within 10% of baseline.
Infection Control — This Is an Aerosol-Generating Procedure
Induction generates a high-volume respirable aerosol from the lower airway, which is exactly why it works and exactly why it is hazardous. Perform induction in an airborne infection isolation room (negative pressure, 6–12 air changes per hour , exhausted outdoors or HEPA-filtered) or a dedicated, well-ventilated booth. Staff wear a fit-tested N95 or PAPR , eye protection, gown, and gloves. Observe the room clearance time before the next occupant enters — roughly 69 minutes at 6 ACH and 35 minutes at 12 ACH for 99.9% removal.
Evaluating Specimen Validity
A specimen that is mostly saliva will grow oropharyngeal flora and mislead treatment. Adequacy is judged microscopically , not by appearance or volume.
For bacteriology (Gram stain screening): an acceptable lower respiratory specimen shows more than 25 neutrophils and fewer than 10 squamous epithelial cells per low-power field . Squamous epithelial cells come from the mouth, so a high count means the specimen is saliva and most laboratories will reject it and request recollection.
Important exception: this screen is not applied to specimens for mycobacteria, fungi, Legionella , or Pneumocystis , where a paucicellular specimen may still be diagnostic.
Neutropenic patients may legitimately produce a specimen with few neutrophils; interpret in context.
For induced cell-count studies , the additional validity criteria are squamous contamination below about 20% of total cells and cell viability above 50% by trypan blue exclusion. Processing should occur within about 2 hours.
Other quality checks: reject a specimen that is unlabeled, that arrives in a leaking or non-sterile container, that was collected after mouthwash rinsing, or that is grossly clear and watery when a purulent specimen was expected. Always document the collection method — an induced specimen is diluted by saline, so cell concentrations from an induced sample cannot be compared directly with those from a spontaneous one.